News & Publications
Stanford Cancer Institute News
-
Navigating Cancer Care With the Stanford Care Coach Program
To help facilitate advanced care planning, Stanford Cancer Care Services implemented the Care Coach Program based on data-driven research.
-
ASH President-Elect: A Look Back on the Path That Led Him Here
In 2023, Negrin was elected president of the American Society of Hematology (ASH) after over 25 years of service to the organization.
-
CAR-T Cell Therapy in Solid Tumors
CAR-T therapy has shown a great benefit in patients with hematologic and lymphatic cancers. However, applying the therapy to solid tumors has proven to be challenging. One of the barriers is T cell exhaustion, where the CAR-T cell becomes dysfunctional.
-
Meryl's Story
Meryl Selig has had a unique experience at the Stanford Cancer Institute (SCI). She began as a patient volunteer in 2009 before being diagnosed with cancer and becoming a patient. She became one of the first patients to receive a novel chimeric antigen receptor (CAR-T) cell therapy when she enrolled in a phase-one clinical trial in 2023.
Stanford Medicine News: Cancer
-
Stanford Medicine-designed AI tools tackle soft tissue sarcomas, identify new treatment strategies
Soft tissue sarcomas are rare and difficult to treat. Machine-learning tools designed at Stanford Medicine uncover distinct cellular communities that correlate with prognosis, immunotherapy success.
-
Diabetes and liver cancer — Stanford Medicine study suggests new screening guidelines
A Stanford Medicine study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased risk for liver cancer who don’t meet current screening guidelines.
-
Metastatic breast cancer treatments have aided decline in deaths, Stanford Medicine-led study finds
Treatment of metastatic disease is responsible for nearly one-third of the decrease in annual deaths from breast cancer from 1975 to 2019, according to a Stanford Medicine-led study.
-
Hodgkin lymphoma prognosis, biology tracked with circulating tumor DNA
Circulating tumor DNA predicts recurrence and splits disease into two subgroups in Stanford Medicine-led study of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.
Scope Blog
Stanford University News: Cancer
- – Stanford News
This protein pic could help develop new cancer treatments | Stanford News
A molecular “snapshot” of a protein can be critical to understanding its function. Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer treatments.
- – Stanford News
A new RNA editing tool could enhance cancer treatment | Stanford News
The new study found that an RNA-targeting CRISPR platform could tune immune cell metabolism without permanent genetic changes, potentially unveiling a relatively low-risk way to upgrade existing cell therapies for cancer.
- – Stanford Report
Shared facilities remove roadblocks to research - Stanford Report
Shared facilities give Stanford’s scientists easier access to state-of-the-art equipment – and push the boundaries for how it can be used.
Media Relations
The Office of Communication & Public Affairs is dedicated to sharing School of Medicine news with the media and helping journalists secure expert interviews, photographs and rich media for stories on medicine and health care.